[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO1985004803A1 - Hyaluronic acid/hyaluronate based fragrance products - Google Patents

Hyaluronic acid/hyaluronate based fragrance products Download PDF

Info

Publication number
WO1985004803A1
WO1985004803A1 PCT/US1984/001848 US8401848W WO8504803A1 WO 1985004803 A1 WO1985004803 A1 WO 1985004803A1 US 8401848 W US8401848 W US 8401848W WO 8504803 A1 WO8504803 A1 WO 8504803A1
Authority
WO
WIPO (PCT)
Prior art keywords
fragrance
hyaluronic acid
salt form
composition
naha
Prior art date
Application number
PCT/US1984/001848
Other languages
French (fr)
Inventor
James W. Bracke
Original Assignee
Diagnostic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic, Inc. filed Critical Diagnostic, Inc.
Publication of WO1985004803A1 publication Critical patent/WO1985004803A1/en
Priority to FI854930A priority Critical patent/FI854930A/en
Priority to NO855224A priority patent/NO855224L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations

Definitions

  • This invention relates generally to the use of hyaluroni ⁇ acid/hyaluronate as a means for achieving molecular encapsulation of various substances.
  • the inven ⁇ tion specifically relates to the use of hyaluronic acid/ hyaluronate as a molecular encapsulant (fixative) for various fragrance products.
  • a fixative in the perfume art is a substance, which, when combined with a fragrance or a cosmetic product including a fragrance, retards the rate of evaporation of the fragrance thus rendering its odor more persistent.
  • a fragrance After a fragrance has been formulated and compounded, it is usually added to a cosmetic product, e.g., alcoholic fragrance solutions and aerosols including perfumes, toilet waters, colognes or bath oils, creams, gels, emollients, lotions, air fresheners, and deoderants .
  • a fragrance may include various perfume oils and mixtures of a wide variety of material (animal and plant) and synthetic fragrant substances.
  • Such fragrant substan ⁇ ces are typically selected from a wide variety of essential oils, absolutes, isolates, expressed oils, animal secre ⁇ tions, resins, gums, balsams, exudations and synthetic aliphatic and aromatic chemicals.
  • fragrance compositions all cos ⁇ metic products and fragrant compositions will be referred to herein generally as fragrance compositions .
  • hyaluronic acid/hyaluronate in fragrance compositions will add other benefits to those preparations in addition to the entrapment of scent.
  • fragrances cause irritation of the skin of some individuals to which those scents are applied.
  • the natural composition of hyaluronic acid/ hyaluronate in combination with the tendency to bind fragrance will reduce the exposure of sensitive skin to direct contact with a fragrance, thus reducing the opportunity for irritation to develop.
  • Hyaluronic acid (hereinafter referred to as "HA” . as well as its salts , such as sodium hyaluronate (hereinafter referred to as "NaHA” ; NaHA is also used to refer generally to any salt form of HA herein) is a known, naturally occuring high viscosity glycosaminoglycan having alternating p 1-3 glucuronidic and /3 1-4 glucosaminidic bonds. It may also be described as a polysaccharide com ⁇ posed of alternate A -D-glucopyranosyluronic acid and 2-acetamido-2-deoxy- ⁇ -D-glucopyranosyl units linked (1 - 3) and (1 - 4), respectively.
  • the molecular weight of this material is generally within the range of 50,000 to 8,000,000 (although there are reports of HA having molecu ⁇ lar weights as high as 13,000,000) depending on the source, method of isolation and method of determination. Typically, it exists in either the acid or the salt form either of which may be used in this invention.
  • animal tissue e.g. in umbilical cord, vitreous humor, synovial fluid, rooster combs, body joints, group A and C hemolytic streptococci and in human skin .
  • HA muccopolysaccharide
  • U.S. Patent 2,975,104 describes the biosynthesis of HA, as does British Patent 1,557,755.
  • Kjems and Lebeck in Acta Path . microbiol . scand. , Section B. , 84t_: 162-164 (1976) describe the strep- tococcal biosynthesis of a relatively low molecular weight HA.
  • HA isolation and characterization of HA is described in Meyer et al, J. Biol . Chem. 107, 629 (1934); J. Biol. Chem., 114, 689 (1936); Balazs, Fed. Proc. 17, 1086 (1958); Laurent et al ; Biochim. Biophys . Acta 42,476 (1960).
  • the structure of HA was elucidated by Weissman et al, J. Am. Chem. Soc. 76, 1753 (1954) and Meyer, Fed. Proc. 17, 1075 (1958).
  • Sodium hyaluronate the salt form of HA
  • HA Sodium hyaluronate
  • Pharmacia AB Uppsala, Sweden
  • AMVISC Med-Chem Products, Inc. (236 West Cummings Park, Woburn, MA 01801) from rooster combs
  • HYALURE TM produced in various grades including a cosmetic grade, by Diagnostic, Inc., 1955 West County Road B2, St., Paul, Minnesota 55113 using microbial fermentation.
  • This invention provides the fixation of various substances by means of HA/NaHA and its ability for molecu ⁇ lar encapsulation. It especially provides improved fra ⁇ grance compositions which exhibit prolonged persistence of the fragrance. This is believed due to the entrapment of the fragrant components of the composition by the HA or NaHA, which is included in the compositions according to this invention. The same persistent fragrance effect is obtained when either HA or NaHA is included in the fragrant compositio . Description of the Preferred Embodiment
  • HA or NaHA used for the purposes of this invention may be obtained or prepared in any variety of ways, as referred to hereinabove.
  • the HA is used in an aqueous solution form.
  • aqueous solution can be prepared in any relative amounts, .005% - 1% NaHA, balance water, being most typi ⁇ cal, the 1% solution being quite viscous (like a rich cream) .
  • Perfume as an example of a fragrance com ⁇ position, is usually composed of a solvent such as alcohol plus a concentrated fragrant essence.
  • the NaHA solution may be mixed with the perfume or any other fragrant com ⁇ position in any relative amount which is not particularly critical. The amount will be determined by the particular objective intended. For example, small amounts may be used to enable one to provide a persistent perfume which main ⁇ tains its normal appearance. Larger amounts may be used to increase persistence and to increase the viscosity of the perfume.
  • KEORA Jean Couturier
  • test results A fresh cotton swab was dipped into the selected test perfume solution (A or B above), wiped on the side of the container neck four times, and a two inch streak placed on the inside of the test subjects' wrist at the beginning of the work day.
  • the opposite wrist received the control solution of that subjects' scent choice (A or B above).
  • the subjects were asked to monitor their wrists to deter ⁇ mine if any difference could be detected during the course of the work day. The subjects did not know the nature of the solutions placed on each wrist.
  • test subjects eight (50%) of the test subjects could distinguish no difference between either the control or the test arm and after the test could't determine scent or odor endpoints of either arm.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)

Abstract

Fragrance products such as perfume and the like compositions which exhibit improved persistence of the fragrance due to the incorporation of HA/NaHA as a fixative therewith.

Description

HYALURONIC ACID/HYALURONATE BASED FRAGRANCE PRODUCTS Background of the Invention
This invention relates generally to the use of hyaluroniσ acid/hyaluronate as a means for achieving molecular encapsulation of various substances. The inven¬ tion specifically relates to the use of hyaluronic acid/ hyaluronate as a molecular encapsulant (fixative) for various fragrance products. A fixative in the perfume art is a substance, which, when combined with a fragrance or a cosmetic product including a fragrance, retards the rate of evaporation of the fragrance thus rendering its odor more persistent.
It has been discovered that hyaluronic acid/ hyaluronate, due to its unique ability for the molecular encapsulation of other substances, functions especially well as a fragrance fixative. This invention will be described further hereinbelow with specific reference to fragrance products. However, it is applicable in its broadest sense to the molecular encapsulation of other substances as well.
After a fragrance has been formulated and compounded, it is usually added to a cosmetic product, e.g., alcoholic fragrance solutions and aerosols including perfumes, toilet waters, colognes or bath oils, creams, gels, emollients, lotions, air fresheners, and deoderants . A fragrance may include various perfume oils and mixtures of a wide variety of material (animal and plant) and synthetic fragrant substances. Such fragrant substan¬ ces are typically selected from a wide variety of essential oils, absolutes, isolates, expressed oils, animal secre¬ tions, resins, gums, balsams, exudations and synthetic aliphatic and aromatic chemicals.
For the purposes of description herein, all cos¬ metic products and fragrant compositions will be referred to herein generally as fragrance compositions . The inclusion of hyaluronic acid/hyaluronate in fragrance compositions will add other benefits to those preparations in addition to the entrapment of scent. First, it is known that certain fragrances cause irritation of the skin of some individuals to which those scents are applied. The natural composition of hyaluronic acid/ hyaluronate in combination with the tendency to bind fragrance will reduce the exposure of sensitive skin to direct contact with a fragrance, thus reducing the opportunity for irritation to develop. Second, there are a similar group of people whose skin chemistry combines with the chemistry of certain fragrances resulting in an undesirable odor combination. The binding of hyaluronic acid/hyaluronate to those fragrances would interfere with those undesirable chemical reactions thus reducing the likelihood for such adverse odors to develop.
Hyaluronic acid (hereinafter referred to as "HA" . as well as its salts , such as sodium hyaluronate (hereinafter referred to as "NaHA" ; NaHA is also used to refer generally to any salt form of HA herein) is a known, naturally occuring high viscosity glycosaminoglycan having alternating p 1-3 glucuronidic and /3 1-4 glucosaminidic bonds. It may also be described as a polysaccharide com¬ posed of alternate A -D-glucopyranosyluronic acid and 2-acetamido-2-deoxy- ^ -D-glucopyranosyl units linked (1 - 3) and (1 - 4), respectively. The molecular weight of this material is generally within the range of 50,000 to 8,000,000 (although there are reports of HA having molecu¬ lar weights as high as 13,000,000) depending on the source, method of isolation and method of determination. Typically, it exists in either the acid or the salt form either of which may be used in this invention.
It is found in animal tissue, e.g. in umbilical cord, vitreous humor, synovial fluid, rooster combs, body joints, group A and C hemolytic streptococci and in human skin .
HA It is the only muccopolysaccharide, among those found in higher animals, that is also produced by microorganisms. For example, U.S. Patent 2,975,104 describes the biosynthesis of HA, as does British Patent 1,557,755. Kjems and Lebeck in Acta Path . microbiol . scand. , Section B. , 84t_: 162-164 (1976) describe the strep- tococcal biosynthesis of a relatively low molecular weight HA.
The isolation and characterization of HA is described in Meyer et al, J. Biol . Chem. 107, 629 (1934); J. Biol. Chem., 114, 689 (1936); Balazs, Fed. Proc. 17, 1086 (1958); Laurent et al ; Biochim. Biophys . Acta 42,476 (1960). The structure of HA was elucidated by Weissman et al, J. Am. Chem. Soc. 76, 1753 (1954) and Meyer, Fed. Proc. 17, 1075 (1958).
Although purity is not particularly critical with respect to this invention, extremely pure HA preparations are available; see, for example, U.S. Patent No. 4,141,973, which describes the preparation and uses of very pure HA.
Sodium hyaluronate, the salt form of HA, is available commercially under several brand names ; one is HEALON^ produced by Pharmacia AB (Uppsala, Sweden), which is obtained from rooster combs; a second is AMVISC produced by Med-Chem Products, Inc. (236 West Cummings Park, Woburn, MA 01801) from rooster combs; and a third is HYALURE produced in various grades including a cosmetic grade, by Diagnostic, Inc., 1955 West County Road B2, St., Paul, Minnesota 55113 using microbial fermentation.
It is known that the softness and flexibility of the stratum corneum, which is the upper layer of the skin, depends on the moisture content of the intercellular chan¬ nels in this layer. Thus, cosmetic chemists have adopted formulations of HA for this purpose. See, for example, U.S. Patent No. 4,303,676. Other uses for HA are described in U.S. Patent No. 4,141,973 and U.S. Patent No. 4,328,803. Summary of the Invention
This invention provides the fixation of various substances by means of HA/NaHA and its ability for molecu¬ lar encapsulation. It especially provides improved fra¬ grance compositions which exhibit prolonged persistence of the fragrance. This is believed due to the entrapment of the fragrant components of the composition by the HA or NaHA, which is included in the compositions according to this invention. The same persistent fragrance effect is obtained when either HA or NaHA is included in the fragrant compositio . Description of the Preferred Embodiment
The HA or NaHA used for the purposes of this invention may be obtained or prepared in any variety of ways, as referred to hereinabove.
Preferably, the HA is used in an aqueous solution form. Such a solution can be prepared in any relative amounts, .005% - 1% NaHA, balance water, being most typi¬ cal, the 1% solution being quite viscous (like a rich cream) .
Perfume, as an example of a fragrance com¬ position, is usually composed of a solvent such as alcohol plus a concentrated fragrant essence. The NaHA solution may be mixed with the perfume or any other fragrant com¬ position in any relative amount which is not particularly critical. The amount will be determined by the particular objective intended. For example, small amounts may be used to enable one to provide a persistent perfume which main¬ tains its normal appearance. Larger amounts may be used to increase persistence and to increase the viscosity of the perfume.
OMPI ^SNATIO TEST FORMULATIONS Test Solutions :
A. One ml. of CHANEL #5 (Chanel, Paris, France) perfume was mixed with 99 ml. of 0.005% NaHA in water. A control of the same solution without NaHA was also prepared.
B. One ml. of KEORA (Jean Couturier) perfume was mixed with 99 ml. of 0.005% NaHA in water. A control of the same solution without NaHA was also prepared.
Test Methods:
A fresh cotton swab was dipped into the selected test perfume solution (A or B above), wiped on the side of the container neck four times, and a two inch streak placed on the inside of the test subjects' wrist at the beginning of the work day. The opposite wrist received the control solution of that subjects' scent choice (A or B above). The subjects were asked to monitor their wrists to deter¬ mine if any difference could be detected during the course of the work day. The subjects did not know the nature of the solutions placed on each wrist. Test Results:
Sixteen test subjects were used. Ten chose solution A; six chose solution B.
Initially, eight (50%) of the test subjects could distinguish no difference between either the control or the test arm and after the test couldn't determine scent or odor endpoints of either arm.
Seven (44%) determined that fragrance on the arm containing perfume plus NaHA persisted longer than the fragrance on the control arm, i.e., the control solu¬ tion.
One { 6% ) determined that the fragrance of the control arm, the control solution, persisted longer than that of the test arm.
If the first eight are disqualified as non-dis¬ criminatory and the resulting eight are considered, the seven subjects choosing the NaHA plus perfume over the control (one subject) becomes an 88 to 13% preference rate for the fragrance persistence effects of NaHA.
Variations and modifications can, of course, be made without departing from the spirit and scope of this invention.

Claims

Having thus described the invention what is claimed is:
1. The use of hyaluronic acid or its salt form in combination with another substance for the purpose of providing a composition in which the other substance is molecularly encapsulated by the hyaluronic acid or its salt form.
2. The use of claim 1 in which the other substance is a fragrance.
3. A fragrance composition consisting essen¬ tially of a quantity of hyaluronic acid or its salt form combined with a fragrance.
4. A perfume or a like composition exhibiting improved persistence of its fragrance on the skin, the com¬ position consisting essentially of a quantity of perfume or the like mixed with a quantity of hyaluronic acid or its salt form.
5. The composition of claim 4 wherein NaHA, the salt form is sodium hyaluronate.
6. The composition of claim 5 including water and only a minor relative amount of the sodium hyaluronate.
7. The composition of claim 4 including only minor relative amounts of hyaluronic acid or its salt form.
8. A fragrance composition including a fragrant component mixed with a quantity of hyaluronic acid and/or its salt form.
PCT/US1984/001848 1984-04-23 1984-11-13 Hyaluronic acid/hyaluronate based fragrance products WO1985004803A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI854930A FI854930A (en) 1984-04-23 1985-12-12 HYALURONSYRA / HYALURONSYRABASERADE PARFYMPRODUKTER.
NO855224A NO855224L (en) 1984-04-23 1985-12-20 HYALURONIC ACID / HYALURONATE-BASED ODOR PRODUCTS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60281384A 1984-04-23 1984-04-23
US602,813 1984-04-23

Publications (1)

Publication Number Publication Date
WO1985004803A1 true WO1985004803A1 (en) 1985-11-07

Family

ID=24412903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1984/001848 WO1985004803A1 (en) 1984-04-23 1984-11-13 Hyaluronic acid/hyaluronate based fragrance products

Country Status (4)

Country Link
EP (1) EP0179070A1 (en)
AU (1) AU3619984A (en)
FI (1) FI854930A (en)
WO (1) WO1985004803A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0700677A1 (en) 1994-09-08 1996-03-13 L'oreal Use of a vegetable compound for the fixation of perfume in a cosmetic and/or dermatological composition
EP3103523A1 (en) 2015-06-12 2016-12-14 The Procter and Gamble Company Absorbent article comprising fragrance composition
EP3103431A1 (en) 2015-06-12 2016-12-14 The Procter and Gamble Company Fragrance compositions and uses thereof
WO2016200759A1 (en) 2015-06-12 2016-12-15 The Procter & Gamble Company Fragrance composition
WO2019156707A1 (en) 2018-02-07 2019-08-15 Coty Inc. Fragrance compositions and uses thereof
WO2021247838A1 (en) 2020-06-05 2021-12-09 Coty Inc. Fragrance composition comprising a fragrance component and a non-odorous fragrance modulator
WO2023055916A1 (en) 2021-09-30 2023-04-06 Coty Inc. Fragrance compositions based on polyurethane
WO2023081742A1 (en) 2021-11-04 2023-05-11 Coty Inc. Ethanol-free fragrance chassis
WO2024137340A1 (en) 2022-12-21 2024-06-27 Coty Inc. Fragrance compositions and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0700677A1 (en) 1994-09-08 1996-03-13 L'oreal Use of a vegetable compound for the fixation of perfume in a cosmetic and/or dermatological composition
US10138441B2 (en) 2015-06-12 2018-11-27 The Procter & Gamble Company Fragrance compositions and uses thereof
US10501706B2 (en) 2015-06-12 2019-12-10 The Procter & Gamble Company Fragrance compositions and uses thereof
WO2016200759A1 (en) 2015-06-12 2016-12-15 The Procter & Gamble Company Fragrance composition
WO2016200761A2 (en) 2015-06-12 2016-12-15 The Procter & Gamble Company Fragrance compositions and uses thereof
EP3141239A1 (en) 2015-06-12 2017-03-15 The Procter and Gamble Company Fragrance compositions and uses thereof
EP3103523A1 (en) 2015-06-12 2016-12-14 The Procter and Gamble Company Absorbent article comprising fragrance composition
US10336966B2 (en) 2015-06-12 2019-07-02 The Procter & Gamble Company Fragrance compositions and uses thereof
EP3103431A1 (en) 2015-06-12 2016-12-14 The Procter and Gamble Company Fragrance compositions and uses thereof
WO2019156707A1 (en) 2018-02-07 2019-08-15 Coty Inc. Fragrance compositions and uses thereof
WO2021247838A1 (en) 2020-06-05 2021-12-09 Coty Inc. Fragrance composition comprising a fragrance component and a non-odorous fragrance modulator
WO2023055916A1 (en) 2021-09-30 2023-04-06 Coty Inc. Fragrance compositions based on polyurethane
WO2023081742A1 (en) 2021-11-04 2023-05-11 Coty Inc. Ethanol-free fragrance chassis
WO2024137340A1 (en) 2022-12-21 2024-06-27 Coty Inc. Fragrance compositions and uses thereof
FR3143998A1 (en) 2022-12-21 2024-06-28 Coty Inc. PERFUME COMPOSITIONS AND THEIR USES

Also Published As

Publication number Publication date
FI854930A0 (en) 1985-12-12
EP0179070A1 (en) 1986-04-30
FI854930A (en) 1985-12-12
AU3619984A (en) 1985-11-15

Similar Documents

Publication Publication Date Title
US5153230A (en) Topical skin cream composition
KR100230830B1 (en) Deodorant composition comprising a water-soluble zinc salt as odour-absorbing agent
US4973473A (en) Skin care preparation
CA1322532C (en) Trehalose containing cosmetic composition and method of using it
US5169631A (en) Topical antimicrobial composition and uses
US3463862A (en) Albumin containing comsmetic lotion
JPS62205008A (en) Additive for cosmetic or the like
US4268526A (en) Cosmetic cream formulation
GB2194888A (en) Composition for inducing and stimulating hair growth
KR930016107A (en) A deodorant composition containing a substance inhibiting bacterial adhesion, a method of using the same, and a method of determining a substance inhibiting bacterial adhesion
JPS61180705A (en) Cosmetic
WO1985004803A1 (en) Hyaluronic acid/hyaluronate based fragrance products
US4263274A (en) Antiperspirant compositions and methods
JPH0768114B2 (en) Bath additive
KR102026365B1 (en) Cosmetic composition comprising uridine and activation complex
JPH0450286B2 (en)
JPH10182411A (en) Preparation for external use for skin
JPH0521085B2 (en)
JPS59231013A (en) Deodorant cosmetics
JP2678138B2 (en) O / W emulsion cosmetic composition containing milk
JPS62178505A (en) Cosmetic
US4761278A (en) Ladies aftershave preparation and method for its manufacture
JPS59186911A (en) Hair cosmetic
JPH08198741A (en) Biological hyarulonic acid synthesis promoter
JP2002145753A (en) Heumectant composition and cosmetic including the same

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): AU DK FI JP NO

AL Designated countries for regional patents

Designated state(s): AT BE CH DE FR GB NL SE

WWE Wipo information: entry into national phase

Ref document number: 854930

Country of ref document: FI

WWE Wipo information: entry into national phase

Ref document number: 1984904297

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1984904297

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1984904297

Country of ref document: EP